| Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia MV Valero, LR Amador, C Galindo, J Figueroa, MS Bello, LA Murillo, ... The Lancet 341 (8847), 705-710, 1993 | 260 | 1993 |
| Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21 O Kashala, R Amador, MV Valero, A Moreno, A Barbosa, B Nickel, ... Vaccine 20 (17-18), 2263-2277, 2002 | 117 | 2002 |
| Frecuencia de factores de riesgo asociados a enfermedades cardiovasculares en población universitaria joven J Hernández-Escolar, Y Herazo-Beltrán, MV Valero Revista de salud pública 12, 852-864, 2010 | 106 | 2010 |
| Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial R Amador, A Moreno, LA Murillo, O Sierra, D Saavedra, M Rojas, AL Mora, ... Journal of Infectious Diseases 166 (1), 139-144, 1992 | 80 | 1992 |
| Compártelo MV Valero, R Amador, JJ Aponte, A Narvaez, C Galindo, Y Silva, J Rosas, ... Vaccine 14 (15), 1466-70, 1996 | 77* | 1996 |
| Malaria in Colombia: retrospective glance during the past 40 years MV Valero-Bernal Revista de Salud Pública 8, 141-149, 2006 | 47 | 2006 |
| Revista de Salud Pública MV Valero-Bernal Revista de Salud Pública 8, 141-149, 2006 | 47* | 2006 |
| Determination of the immunization schedule for field trials with the synthetic malaria vaccine SPf 66 CL Rocha, LA Murillo, AL Mora, M Rojas, L Franco, J Cote, MV Valero, ... Parasite immunology 14 (1), 95-109, 1992 | 36 | 1992 |
| Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer M Ruiz, J Salvador, J Bayo, M Lomas, A Moreno, M Valero, R Bernabe, ... Cancer chemotherapy and pharmacology 62 (6), 1085-1090, 2008 | 28 | 2008 |
| The frequency of cardiovascular disease-associated risk factors in a university student population J Hernández-Escolar, Y Herazo-Beltrán, MV Valero Revista de salud pública 12 (5), 852-864, 2010 | 16 | 2010 |
| Assessing options for an innovative malaria control program on the basis of experience with the New Colombian Health Social Security System CA Agudelo C, A Corredor A, MV Valero Revista de salud pública 6, 1-39, 2004 | 15 | 2004 |
| Assessing options for an innovative malaria control program on the basis of experience with the New Colombian Health Social Security System C Agudelo, A Carlos, A Corredor, MV Valero Revista de Salud Pública 6, 1-39, 2004 | 15 | 2004 |
| Proporción de fiebre atribuible a malaria en Colombia: Indicadores potenciales para el seguimiento hacia la eliminación MV Valero Revista de Salud Pública 19 (1), 45-51, 2017 | 13* | 2017 |
| Revista de Salud Pública ED Hernández-Álvarez, MV Valero-Bernal, EM Mancera-Soto Revista de Salud Pública 17, 120-131, 2015 | 10* | 2015 |
| Efficacy of the prescription of physical activity in the obese child population ED Hernández-Álvarez, MV Valero-Bernal, EM Mancera-Soto Revista de Salud Pública 17 (1), 120-131, 2015 | 10 | 2015 |
| Globalización y salud: el caso de las enfermedades tropicales y olvidadas M Valero-Bernal, M Tanne Revista MVZ Córdoba 13 (1), 1252-1264, 2008 | 9 | 2008 |
| Proportion of fever attributable to malaria in Colombia: Potential indicators for monitoring progress towards malaria elimination MV Valero-Bernal, M Tanner, S Muñoz-Navarro, JF Valero-Bernal Revista de Salud Pública 19 (1), 81-90, 2017 | 8 | 2017 |
| Políticas sanitarias y situación actual del Bocio Endémico: El caso de Colombia MVV Bernal, RF Vega, AM Chaves, JS Montero Revista de la Facultad de Medicina 60 (4), 343-351, 2012 | 6 | 2012 |
| Radiology and Imaging P Valero, E Gomez-Gonzalez, A Sabino, M Valero, J Suárez-Ramos | 6* | 2010 |
| GLOBALIZATION AND HEALTH: The case of tropical and neglected diseases M Valero-Bernal, M Tanner Revista MVZ Córdoba 13 (1), 1252-1264, 2008 | 6 | 2008 |
MANUEL ELKIN PATARROYO MURIL...Fundación Instituto de Inmunología de Colombia (FIDIC)Dirección de correo verificada de fidic.org.co
